HMG 150 IU

Support. Stimulate. Reproduce.

HMG (Human Menopausal Gonadotropin) 150 IU is a gonadotropin preparation with both FSH (Follicle-Stimulating Hormone) and LH (Luteinizing Hormone) activity, used clinically in specific fertility-treatment settings under medical supervision.

Unlike experimental research peptides, HMG has an established role in reproductive medicine, where its FSH/LH activity can stimulate gonadal function in appropriately selected patients.

---

The Science of Gonadotropin Support

HMG provides two key gonadotropin activities:

FSH Activity

• In women: FSH supports ovarian follicular development and maturation.
• In men: FSH plays an important role in Sertoli-cell function and spermatogenesis, supporting the biological process involved in sperm production.

LH Activity

• In women: LH contributes to ovarian steroidogenesis and the reproductive cycle.
• In men: LH activity supports Leydig-cell stimulation and intratesticular testosterone production, which is important for normal spermatogenesis.

The result: FSH + LH activity → targeted reproductive and fertility support.

---

Key Clinical Applications

• Supports follicular development in selected female fertility protocols
• Used within medically supervised ovulation-induction programs
• Supports spermatogenesis in appropriately diagnosed male infertility
• Provides combined FSH and LH activity
• Supports gonadal stimulation in selected hypogonadotropic conditions
• Can form part of assisted reproductive technology protocols
• Supports reproductive endocrinology treatment strategies

---

Designed for Reproductive Medicine

HMG may be prescribed in clinical settings involving:

• Female infertility
• Follicular stimulation
• Assisted reproductive technology
• Male hypogonadotropic hypogonadism
• Impaired spermatogenesis related to gonadotropin deficiency
• Selected male fertility-restoration protocols

---

Product Details

Human Menopausal Gonadotropin (HMG)

FSH + LH Activity
Total: 150 IU

• HMG (150 IU): Gonadotropin & Fertility Support

---

Male Fertility Perspective

In men, adequate FSH stimulation is particularly important for Sertoli-cell activity and sperm development.

HMG may therefore be incorporated into specialist fertility protocols when the objective is to support or restore spermatogenesis, particularly where endogenous gonadotropin signaling is inadequate.

Depending on the underlying diagnosis, clinicians may use HMG as part of a broader protocol involving other gonadotropin therapy. Treatment selection should be based on hormone testing and fertility evaluation rather than testosterone levels alone.

---

Female Fertility Perspective

In women, HMG provides gonadotropin stimulation that can promote the development of ovarian follicles.

Because ovarian response can vary substantially between individuals, treatment typically requires professional monitoring, which may include:

• Ultrasound assessment of follicular development
• Estradiol monitoring
• Individualized dose adjustment
• Timing of ovulation or assisted-reproduction procedures

---

Possible Side Effects

Potential adverse effects depend on the patient and treatment protocol.

In men, these may include:

• Injection-site reactions
• Headache
• Breast tenderness or gynecomastia
• Acne or hormonal changes
• Fluid retention

In women, potential effects include:

• Abdominal or pelvic discomfort
• Headache
• Injection-site reactions
• Ovarian enlargement
• Multiple pregnancy
• Ovarian Hyperstimulation Syndrome (OHSS), which can become serious

---

Medical Monitoring

HMG is a pharmacologically active fertility medication, so dosing should be individualized by a qualified clinician.

Depending on the treatment objective, monitoring may include reproductive hormones, semen analysis in men, and ultrasound/hormonal monitoring in women.

A fixed universal dosing schedule should not be determined solely from the 150 IU vial strength.

---

Scientific Perspective

Gonadotropin therapy has an established place in reproductive endocrinology.

The combination of FSH and LH activity allows HMG to influence key processes involved in ovarian follicular development in women and testicular reproductive function in men.

The appropriate protocol depends heavily on the underlying cause of infertility, baseline hormone levels, sex, reproductive goals, and response to treatment.

---

Why Choose Stayfit Pharma

When quality matters, precision defines the difference.

• Precisely formulated gonadotropin preparation
• Strict manufacturing and quality-control standards
• Designed for professional reproductive applications
• Consistent formulation and product integrity

---

HMG 150 IU
Human Menopausal Gonadotropin (FSH + LH Activity)
Support • Stimulate • Reproduce